What it Does
MedVynt™ supports post-clearance execution for medical device and SaMD teams. It helps teams identify misalignment between cleared intent, evolving execution, and AI usage early in day-to-day operations, before issues escalate into rework, inspections, or delays.
The outcome: faster execution with fewer interruptions. MedVynt™ operates after clearance and upstream of post-market surveillance.
Why Teams Use It
Support growth without slowing execution
-
Reduce late-stage Regulatory Affairs intervention
-
Keep product, commercial, and field teams aligned
-
Preserve timelines without adding headcount
Who Its For
Regulatory Affairs & Quality
-
Earlier visibility into post-clearance alignment and boundary signals
Product, Commercial Operations & Sales Enablement
-
Cleaner execution, fewer corrections, faster enablement
Executive Leadership (GM, VP, CFO)
-
Predictable timelines and protected commercial momentum
Digital, Procurement & IT
-
Low-lift deployment within existing systems and controls.
Why Now
After clearance, many devices, rules and regulations, especially in software and AI-enabled products, keep changing.
When execution drifts faster than governance, risk accumulates quietly.
MedVynt™ surfaces that drift early, so teams can correct course while there’s still time.
What It Is Not
-
Not a clearance or submission tool
-
Not post-market surveillance
-
Not clinical or patient-data related
-
Not a replacement for RA or Quality
It supports post-clearance compliance continuity.
What it Does
MedVynt™ Tracks
Cleared intent & use boundaries
Regulatory classification signals (incl. SaMD)
AI governance boundaries
(use vs non-use, human-in-the-loop)
Claims and field messaging drift
Software and feature changes
Evolving regulatory expectations
(affecting execution)
Built to Fit Your Stack
MedVynt™ operates upstream of formal review and content systems, helping teams enter downstream workflows with cleaner, more defensible materials.
After clearance, devices, especially software and AI-enabled products keep changing.
When execution drifts faster than governance, risk accumulates quietly.
MedVynt™ surfaces that drift early, so teams can correct course while there’s still time
It can complement environments where teams use systems such as Veeva PromoMats®, helping content owners and cross-functional teams enter downstream review with greater alignment and fewer avoidable revisions.
Credibility and Assurance
-
Human-in-the-loop by design – advisory support only
-
No auto-approval – reviewers retain full authority
-
Audit-ready workflows – time-stamped logs and version history
-
Configurable controls – enterprise-aligned hosting and retention
-
Workflow-compatible – operates upstream of existing systems
-
Works Alongside Your Existing Review Systems
MedVynt™ is designed to operate upstream of enterprise content and review platforms, supporting cleaner execution before materials enter formal workflows.
MedVynt™ does not replace, modify, or automate decisions within formal review or approval systems.
Perform a 90 Day Pilot
Clearly defined metrics
-
First-pass approval rate
-
Revision count
-
Cycle time
-
Error-class reduction